Table 2.
Comprehensive literature analysis of predicting EGFR mutation in primary NSCLC based on MRI radiomics from extrapulmonary metastases
| Author | Year | N | EGFR mutation (±) | AUC | TP | FP | FN | TN | Metastases | Cohort |
|---|---|---|---|---|---|---|---|---|---|---|
| Cao R-T | 2022 | 100 | 49/51 | 0.97 | 47 | 5 | 2 | 46 | Brain | Training |
| Cao R-V1 | 2022 | 50 | 24/26 | 0.90 | 20 | 2 | 4 | 24 | Brain | Validation 1 |
| Cao R-V2 | 2022 | 38 | 19/19 | 0.90 | 17 | 2 | 2 | 17 | Brain | Validation 2 |
| Fan Y-T | 2022-1 | 153 | 90/63 | 0.95 | 79 | 4 | 11 | 59 | Brain | Training |
| Fan Y-V1 | 2022-1 | 77 | 45/32 | 0.88 | 33 | 1 | 12 | 31 | Brain | Validation 1 |
| Fan Y-V2 | 2022-1 | 80 | 40/40 | 0.90 | 35 | 8 | 5 | 32 | Brain | Validation 2 |
| Fan Y-T | 2022-2 | 106 | 54/52 | 0.84 | 39 | 8 | 15 | 44 | Spine | Training |
| Fan Y-V1 | 2022-2 | 54 | 28/26 | 0.81 | 25 | 7 | 3 | 19 | Spine | Validation 1 |
| Fan Y-V2 | 2022-2 | 32 | 18/14 | 0.75 | 14 | 4 | 4 | 10 | Spine | Validation 2 |
| Cao R-T | 2023 | 171 | 91/80 | 0.81 | 61 | 11 | 30 | 69 | Spine | Training |
| Cao R-V1 | 2023 | 86 | 46/40 | 0.75 | 32 | 11 | 14 | 29 | Spine | Validation 1 |
| Cao R-V2 | 2023 | 42 | 24/18 | 0.74 | 17 | 4 | 7 | 14 | Spine | Validation 2 |
| Huang Z-T | 2024 | 86 | 45/41 | 0.76 | 34 | 10 | 11 | 31 | Brain | Training |
| Huang Z-V | 2024 | 37 | 19/18 | 0.79 | 14 | 3 | 5 | 15 | Brain | Validation |